These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9090611)

  • 41. The gradient of retinal functional changes during acute intraocular pressure elevation.
    Bui BV; Edmunds B; Cioffi GA; Fortune B
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):202-13. PubMed ID: 15623775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transnitrosation as a predominant mechanism in the hypotensive effect of S-nitrosoglutathione.
    Park JW; Billman GE; Means GE
    Biochem Mol Biol Int; 1993 Aug; 30(5):885-91. PubMed ID: 8106071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and evaluation of NO-release from symmetrically substituted furoxans.
    Nirode WF; Luis JM; Wicker JF; Wachter NM
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2299-301. PubMed ID: 16446086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fates and vascular action of S-nitrosoglutathione and related compounds in the circulation.
    Kashiba M; Kasahara E; Chien KC; Inoue M
    Arch Biochem Biophys; 1999 Mar; 363(2):213-8. PubMed ID: 10068442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional changes in the retina during and after acute intraocular pressure elevation in mice.
    Kong YX; Crowston JG; Vingrys AJ; Trounce IA; Bui VB
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5732-40. PubMed ID: 19643960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ocular perfusion pressure on retinal function in the rabbit.
    Harrison JM; Kiel JW; Smith S
    Vision Res; 1997 Sep; 37(17):2339-47. PubMed ID: 9381670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of glutathione in nitric oxide-dependent regulation of energy metabolism in rat hepatoma cells.
    Nishikawa M; Sato EF; Kashiba M; Kuroki T; Utsumi K; Inoue M
    Hepatology; 1998 Feb; 27(2):422-6. PubMed ID: 9462640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
    MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
    J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent.
    Young DV; Serebryanik D; Janero DR; Tam SW
    Mol Cell Biol Res Commun; 2000 Jul; 4(1):32-6. PubMed ID: 11152625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic effects of S-nitroso-glutathione in the human following intravenous infusion.
    Ramsay B; Radomski M; De Belder A; Martin JF; Lopez-Jaramillo P
    Br J Clin Pharmacol; 1995 Jul; 40(1):101-2. PubMed ID: 8527258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic hypertension increases susceptibility to acute IOP challenge in rats.
    He Z; Vingrys AJ; Armitage JA; Nguyen CT; Bui BV
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7888-95. PubMed ID: 25370512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.
    Calmels S; Hainaut P; Ohshima H
    Cancer Res; 1997 Aug; 57(16):3365-9. PubMed ID: 9269997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of crocin analogs on ocular blood flow and retinal function.
    Xuan B; Zhou YH; Li N; Min ZD; Chiou GC
    J Ocul Pharmacol Ther; 1999 Apr; 15(2):143-52. PubMed ID: 10229492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional role of nitric oxide in regulation of ocular blood flow.
    Koss MC
    Eur J Pharmacol; 1999 Jun; 374(2):161-74. PubMed ID: 10422757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase of ocular blood flow by some phytogenic compounds.
    Liu SX; Chiang CH; Yao QS; Chiou GC
    J Ocul Pharmacol Ther; 1996; 12(2):95-101. PubMed ID: 8773925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of glutathione S-transferases from rat liver by S-nitroso-L-glutathione.
    Clark AG; Debnam P
    Biochem Pharmacol; 1988 Aug; 37(16):3199-201. PubMed ID: 3401252
    [No Abstract]   [Full Text] [Related]  

  • 57. Facilitation of retinal function recovery by natural products after temporary ischemic occlusion of central retinal artery.
    Chiou GC; Li BH; Wang MS
    J Ocul Pharmacol; 1994; 10(2):493-8. PubMed ID: 8083568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitric oxide alters chondrocyte function by disrupting cytoskeletal signaling complexes.
    Clancy R
    Osteoarthritis Cartilage; 1999 Jul; 7(4):399-400. PubMed ID: 10419779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit.
    Cao W; Zaharia M; Drumheller A; Casanova C; Lafond G; Brunette JR; Jolicoeur FB
    Curr Eye Res; 1994 Feb; 13(2):97-102. PubMed ID: 8194364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of HELLP syndrome with nitric oxide donor.
    de Belder A; Lees C; Martin J; Moncada S; Campbell S
    Lancet; 1995 Jan; 345(8942):124-5. PubMed ID: 7815862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.